Inhibitors of HIF and angiogenesis
US9062072B2 · kind B2 · utility
2Cited by
2References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 20, 2011 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Jan 8, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Inhibitors of the Hypoxia Inducible Factor (HIF) and angiogenesis and their methods of use including the treatment of cancer, hypoxia related pathologies, disorders leading to ischemia, for example stroke and ischemic heart disease, and non-cancerous angiogenic diseases are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.